{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:39:58Z","timestamp":1783939198852,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"publisher","award":["Career development program filling the gap"],"award-info":[{"award-number":["Career development program filling the gap"]}],"id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1038\/s41433-023-02747-x","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T16:02:40Z","timestamp":1695916960000},"page":"620-624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effects of hydroxychloroquine therapy on choroidal volume and choroidal vascularity index"],"prefix":"10.1038","volume":"38","author":[{"given":"Nasiq","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Driban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rasheed","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swen","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakira","family":"Yoosuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Barthelmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran Kumar","family":"Vupparaboina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayss","family":"Al-Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1772-3558","authenticated-orcid":false,"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"2747_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier E, D\u00f6rner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020;16:155\u201366.","journal-title":"Nat Rev Rheumatol"},{"key":"2747_CR2","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/eye.2016.298","volume":"31","author":"IH Yusuf","year":"2017","unstructured":"Yusuf IH, Sharma S, Luqmani R, Downes SM. Hydroxychloroquine retinopathy. Eye. 2017;31:828\u201345.","journal-title":"Eye"},{"key":"2747_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","volume":"118","author":"MF Marmor","year":"2011","unstructured":"Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF, American Academy of Ophthalmology. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology. 2011;118:415\u201322.","journal-title":"Ophthalmology"},{"key":"2747_CR4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/jamaophthalmol.2014.1099","volume":"132","author":"MF Marmor","year":"2014","unstructured":"Marmor MF, Hu J. Effect of disease stage on progression of hydroxychloroquine retinopathy. JAMA Ophthalmol. 2014;132:1105\u201312.","journal-title":"JAMA Ophthalmol"},{"key":"2747_CR5","first-page":"3786","volume":"63","author":"CH Min","year":"2022","unstructured":"Min CH, Lee JY, Yoon YH. Longitudinal changes in outer nuclear layer and choroidal thickness in patients using hydroxychloroquine before development of retinopathy. Investig Ophthalmol Vis Sci. 2022;63:3786.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2747_CR6","doi-asserted-by":"publisher","first-page":"102806","DOI":"10.1016\/j.pdpdt.2022.102806","volume":"38","author":"OA Polat","year":"2022","unstructured":"Polat OA, Ok\u00e7u M, Y\u0131lmaz M. Hydroxychloroquine treatment alters retinal layers and choroid without apparent toxicity in optical coherence tomography. Photodiagnosis Photodyn Ther. 2022;38:102806.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"2747_CR7","first-page":"2","volume":"84","author":"E Cinar","year":"2021","unstructured":"Cinar E, Yuce B, Aslan F. Evaluation of retinal and choroidal microvascular changes in patients who received hydroxychloroquine by optical coherence tomography angiography. Arq Bras Oftalmol. 2021;84:2\u201310.","journal-title":"Arq Bras Oftalmol"},{"key":"2747_CR8","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1136\/bjophthalmol-2018-313679","volume":"105","author":"R Forte","year":"2021","unstructured":"Forte R, Haulani H, Dyrda A, J\u00fcrgens I. Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests. Br J Ophthalmol. 2021;105:1297\u2013301.","journal-title":"Br J Ophthalmol"},{"key":"2747_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ajo.2017.08.022","volume":"183","author":"SJ Ahn","year":"2017","unstructured":"Ahn SJ, Ryu SJ, Joung JY, Lee BR. Choroidal thinning associated with hydroxychloroquine retinopathy. Am J Ophthalmol. 2017;183:56\u201364.","journal-title":"Am J Ophthalmol"},{"key":"2747_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.survophthal.2018.11.002","volume":"64","author":"SR Singh","year":"2019","unstructured":"Singh SR, Vupparaboina KK, Goud A, Dansingani KK, Chhablani J. Choroidal imaging biomarkers. Surv Ophthalmol. 2019;64:312\u201333.","journal-title":"Surv Ophthalmol"},{"key":"2747_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/jcm9020595","volume":"9","author":"C Iovino","year":"2020","unstructured":"Iovino C, Pellegrini M, Bernabei F, Borrelli E, Sacconi R, Govetto A, et al. Choroidal vascularity index: an in-depth analysis of this novel optical coherence tomography parameter. J Clin Med. 2020;9:595.","journal-title":"J Clin Med"},{"key":"2747_CR12","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1097\/IAE.0000000000001040","volume":"36","author":"R Agrawal","year":"2016","unstructured":"Agrawal R, Chhablani J, Tan KA, Shah S, Sarvaiya C, Banker A. Choroidal vascularity index in central serous chorioretinopathy. Retina. 2016;36:1646\u201351.","journal-title":"Retina"},{"key":"2747_CR13","unstructured":"StataCorp LP. Stata statistical software: release 16. College Station, TX. 2019."},{"key":"2747_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","volume":"23","author":"KD Rainsford","year":"2015","unstructured":"Rainsford KD, Parke AL, Clifford-Rashotte M, Kean WF. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis, and related diseases. Inflammopharmacology. 2015;23:231\u201369.","journal-title":"Inflammopharmacology"},{"key":"2747_CR15","unstructured":"Dardenne MU, Nordmann J. Biochemistry of the Eye: Symposium at Tutzing Castle, August 10-13, 1966. Munich: Karger; 1968."},{"key":"2747_CR16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1097\/IAE.0000000000002047","volume":"39","author":"SJ Ahn","year":"2019","unstructured":"Ahn SJ, Ryu SJ, Lim HW, Lee BR. Toxic effects of hydroxychloroquine on the choroid: evidence from multimodal imaging. Retina. 2019;39:1016\u201326.","journal-title":"Retina"},{"key":"2747_CR17","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00417-018-4117-3","volume":"256","author":"M Bulut","year":"2018","unstructured":"Bulut M, Ak\u0131dan M, G\u00f6zkaya O, Erol MK, Cengiz A, \u00c7ay HF. Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations. Graefes Arch Clin Exp Ophthalmol. 2018;256:2075\u201381.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2747_CR18","first-page":"5715","volume":"60","author":"M Iqbal","year":"2019","unstructured":"Iqbal M, Wong WT, Chew EY, Cukras CA. Comparison of choroidal and retinal thicknesses in patients with and without hydroxychloroquine toxicity. Investig Ophthalmol Vis Sci. 2019;60:5715.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2747_CR19","unstructured":"Y\u0131lmaz H, Ak\u0131nc\u0131o\u011flu D, Kucukevcilioglu M, \u00d6zge G, Durukan A, Mutlu F. Choroidal thickness in patients using hydroxychloroquine without retinal toxicity. Hitit Med J. 2020;2:73\u20138."},{"key":"2747_CR20","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1080\/09273948.2017.1278777","volume":"26","author":"O Karti","year":"2018","unstructured":"Karti O, Ayhan Z, Zengin MO, Kaya M, Kusbeci T. Choroidal thickness changes in rheumatoid arthritis and the effects of short-term hydroxychloroquine treatment. Ocul Immunol Inflamm. 2018;26:770\u20135.","journal-title":"Ocul Immunol Inflamm"},{"key":"2747_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3109\/09273948.2015.1024329","volume":"24","author":"N Duru","year":"2016","unstructured":"Duru N, Altinkaynak H, Erten \u015e, Can ME, Duru Z, U\u011furlu FG, et al. Thinning of choroidal thickness in patients with rheumatoid arthritis unrelated to disease activity. Ocul Immunol Inflamm. 2016;24:246\u201353.","journal-title":"Ocul Immunol Inflamm"},{"key":"2747_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/IAE.0000000000001193","volume":"37","author":"CS Ferreira","year":"2017","unstructured":"Ferreira CS, Beato J, Falc\u00e3o MS, Brand\u00e3o E, Falc\u00e3o-Reis F, Carneiro \u00c2M. Choroidal thickness in multisystemic autoimmune diseases without ophthalmologic manifestations. Retina. 2017;37:529\u201335.","journal-title":"Retina"},{"key":"2747_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1177\/0961203319828525","volume":"28","author":"J Braga","year":"2019","unstructured":"Braga J, Rothwell R, Oliveira M, Rodrigues D, Fonseca S, Varandas R, et al. Choroid thickness profile in patients with lupus nephritis. Lupus. 2019;28:475\u201382.","journal-title":"Lupus"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02747-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02747-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02747-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T13:05:59Z","timestamp":1707483959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02747-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2747"],"URL":"https:\/\/doi.org\/10.1038\/s41433-023-02747-x","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"18 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Study approved by the Institutional review board of Swiss ethics\/BASEC 240 (No. 2019-00972).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}